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Original Article
Influence of Third-generation Cephalosporin Resistance on Adult 
In-hospital Mortality From Post-neurosurgical Bacterial Meningitis
Chia-Jung Chang, Jung-Jr Ye, Chien-Chang Yang, Po-Yen Huang, Ping-Cherng Chiang, Ming-Hsun Lee*
Division of Infectious Diseases, Department of Internal Medicine, Chang Gung Memorial Hospital,
 Chang Gung University College of Medicine, Taoyuan, Taiwan.
BACKGROUND/PURPOSE: To investigate the clinical features, etiology and predictors of in-hospital 
mortality in adults with post-neurosurgical bacterial meningitis.
METHODS: This retrospective analysis included 60 adult patients with culture-proven post-neurosurgical 
bacterial meningitis hospitalized between September 2006 and August 2008.
RESULTS: Of the 60 patients, 88.3% had monomicrobial infection and 11.7% had mixed infection. The 
mean duration from the first neurosurgical procedure to the diagnosis of meningitis was 21 days (range,
1–134 days). The median frequency of neurosurgical procedure before meningitis was 1 (range, 1–5). 
A total of 69 isolates were identified from the cerebrospinal fluid, the most common pathogens were 
Gram-negative bacilli (43, 62.3%), followed by Gram-positive bacteria (24, 34.8%). The three most common 
Gram-negative bacilli were Serratia marcescens (7, 10.1%), Klebsiella pneumoniae (6, 8.7%), and Enterobacter 
cloacae (4, 5.8%). Pseudomonas aeruginosa and Acinetobacter baumannii isolates comprised less than 3%. 
Notably, glucose non-fermenting Gram-negative bacilli other than Acinetobacter and Pseudomonas spp. 
accounted for 11.6% of the total. Of the Gram-negative bacilli, resistance rates to the third-generation 
cephalosporins, ceftriaxone and ceftazidime, were 58.1% and 34.9%, respectively. The two most common 
Gram-positive pathogens were Staphylococcus aureus (10, 14.5%) and coagulase-negative staphylococci 
(including S. epidermidis) (10, 14.5%). The in-hospital mortality rate was 15.0%, which was significantly 
related to Gram-negative bacilli resistant to third-generation cephalosporins in multivariate analysis 
(adjusted odds ratio = 33.65; p = 0.047).
CONCLUSION: These findings may portend the spread of serious resistance to third-generation cepha-
losporins in nosocomial Gram-negative bacilli throughout the neurosurgical units, suggestive of the need to 
reassess the empirical use of third-generation cephalosporins in post-neurosurgical bacterial meningitis.
KEYWORDS: bacterial meningitis, Gram-negative bacilli, post-neurosurgical
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Introduction
Post-neurosurgical bacterial meningitis is not common 
and there is little published in the literature in English. 
The exact incidence of meningitis after neurosurgical pro-
cedures is variable and is yet unknown, but the reported 
incidence varies from 0.3% to 0.8%.1 Post-neurosurgical 
meningitis is a potentially life-threatening infection of 
the central nervous system (CNS) and is associated with 
worsening of neurological outcome and increased mor-
tality.2 It has become an important subgroup of bacterial 
meningitis within the hospital setting. Surgical pro-
cedures most commonly related to bacterial meningitis 
include craniotomy for head injury, brain tumor or 
intracranial hemorrhage, external ventricular device 
placement, ventriculoperitoneal shunt implantation and 
ventriculostomy.3 The diagnosis of bacterial meningitis 
following neurosurgery is often difficult due to a lack 
of specificity regarding the relevant clinical features and 
laboratory findings.
The prevalence rates for pathogens causing bacterial 
meningitis vary with time, geographical distribution, 
age, underlying medical and/or surgical conditions, and 
mode of infection.4–6 The epidemiologic changes in bacte-
rial meningitis may alter clinicians’ behavior regarding 
antibiotic prescription.7,8 Antimicrobial therapy for post-
neurosurgical meningitis is complicated by the emergence 
of multi-antibiotic resistant strains in recent years. This 
trend and poor penetration of some antimicrobial agents 
into the cerebrospinal fluid (CSF) impose limitations on 
antimicrobial selection.
Potential consequences from the increasing frequency 
of neurosurgical procedures and the widespread use of 
empirical vancomycin and antipseudomonal β-lactam an-
tibiotics, particularly third-generation cephalosporins, for 
post-neurosurgical infections7 may have led to the change 
in the hospital epidemiology and clinical spectrum of 
post-neurosurgical meningitis seen in recent years.9 Thus 
we conducted a 2-year retrospective analysis of consecu-
tive episodes of post-neurosurgical bacterial meningitis 
among a predominantly adult population to investigate 
the etiology, clinical characteristics, laboratory, microbiol-
ogy and antimicrobial therapy of post-neurosurgical bac-
terial meningitis, and analyzed their impact on in-hospital 
mortality.
Methods
Patients and study design
Adult patients (age ≥ 16 years) with a diagnosis of bacte-
rial meningitis after a neurosurgical procedure and with 
relevant CSF cultures positive for one or more bacterial 
organisms between September 2006 and August 2008 
were retrospectively identified through the computer da-
tabase of discharge diagnosis in the Clinical Microbiology 
department at Chang Gung Memorial Hospital–Linkou 
Medical Center, a 3,300-bed university hospital and terti-
ary referral center in northern Taiwan, providing 260 
ordinary neurosurgical beds and 32 intensive-care-unit 
beds. Patients having partial treatment at other hospitals 
and subsequently transferred to the Clinical Microbiology 
Department at Chang Gung Memorial Hospital–Linkou 
Medical Center were excluded. Patients with evidence of 
concomitant chronic meningitis or encephalitis not due 
to bacterial pathogens were also excluded.
Data collected from the enrolled patients included 
demographic characteristics, comorbid illness, conditions 
for neurosurgery, clinical features, laboratory data, bacte-
riology, antimicrobial susceptibility testing, treatment 
modalities and clinical outcomes. Comorbid illnesses 
included hepatic dysfunction with a serum bilirubin 
level ≥ 2.0 mg/dL or liver cirrhosis, renal insufficiency 
with a serum creatinine level ≥ 2.0 mg/dL or a requirement 
for hemodialysis, chronic pulmonary disease, cardiac dis-
ease, diabetes mellitus, and hematological or solid organ 
malignancies. Patient outcomes were classified into 
“survival” and “deceased” (in-hospital mortality) groups 
to elucidate the contributing factors.
Definitions
The diagnostic criteria for a definite bacterial meningitis 
included micro-organisms being isolated in one or more 
CSF cultures and at least one of the following: (1) clinical 
features consistent with meningitis, including fever, con-
sciousness disturbance, seizure, or signs of meningeal ir-
ritation; and (2) consistent CSF findings, a decreased 
glucose concentration (CSF/serum glucose ratio < 0.3 or 
CSF glucose < 50 mg/dL if serum glucose was not availa-
ble), increased lactate (> 18.9 mg/dL) and protein concen-
trations (> 32 mg/dL), and pleocytosis (≥ 10 white blood 
cells/uL) with a predominance of polymorphonuclear 
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cells.4,6 “Post-neurosurgical” meningitis was defined as 
meningitis developed within 3 months of a neurosurgical 
procedure. “Recurrence” of meningitis was defined as two 
or more episodes caused by a different bacterial pathogen, 
or a second or further episode due to the same organism 
with a more than 3-week interval after the completion 
of therapy for the initial episode. “Relapse” of meningitis 
was considered if it was caused by the same organism 
within 3 weeks of the completion of therapy for the initial 
episode.4 Consecutive cultures growing the same bacterial 
organism, or consecutive cultures within 7 days growing 
different pathogens, were regarded as the same episode.
Mixed bacterial meningitis was defined as two or more 
bacterial organisms isolated from the initial CSF culture.10 
Contamination was defined as growth of bacterial patho-
gen from the CSF in a patient without clinical features 
of meningitis and consistent CSF findings. ‘‘Bacteremia” 
was defined as the isolation of bacterial pathogens in 
more than one set of blood cultures. Fever was defined as 
an ear temperature ≥ 38°C. Shock was defined as systolic 
blood pressure ≤ 90 mmHg measured on the same day 
as the collection of blood cultures and was unrelated to 
other possible causes of shock, e.g. hypovolemic and car-
diogenic shock. Respiratory failure was defined as the 
need for endotracheal intubation with mechanical venti-
lator support. Third-generation cephalosporin-resistant 
Gram-negative bacilli (GNB) refer to GNB resistant to 
at least one antibiotic (either ceftriaxone or ceftazidime). 
Appropriate antimicrobial therapy was defined as the ad-
ministration of antimicrobial agents that were effective 
in vitro according to drug susceptibility testing and were 
capable of passing through the blood-brain barrier to 
achieve potentially therapeutic levels.
Microbiology
The antimicrobial susceptibility testing of each isolate was 
performed using the disk diffusion method according to 
Clinical and Laboratory Standards Institute criteria.12
Statistical analysis
All statistical analyses were done using SPSS version 15.0 
(SPSS Inc., Chicago, IL, USA). Tests performed in univari-
ate analysis were χ2 or Fisher’s exact test for categorical 
variables and Student’s t test for continuous variables, as 
appropriate. Odds ratio (OR) and 95% confidence interval 
(CI) were calculated to evaluate the strength of any asso-
ciation as well as the precision of the estimate of effect in 
the outcome analysis. All variables with a p value of 
< 0.1 in univariate analysis and variables of interest (e.g. 
third-generation cephalosporin-resistant or -sensitive GNB) 
were included in a logistic regression model for multivariate 
analysis. All tests were two-tailed, and a p value of < 0.05 
was considered significant.
Results
During the 2-year study period, 704 adult patients had 
a diagnosis of bacterial meningitis and a total of 71 epi-
sodes in 60 patients with culture-proven bacterial menin-
gitis after neurosurgical procedures were included. Patients’ 
demographics, associated neurosurgical conditions, clini-
cal features and laboratory data are summarized in Table 1. 
Of the 60 patients, 30 were men and 30 were women, with 
a mean age of 56 years (range, 16–82 years), representing 
a population of seniority. Fifty-three patients had a single 
episode of post-neurosurgical meningitis. Seven patients 
who had more than one episode were included in the cate-
gory of ‘‘recurrent meningitis”.
The conditions for performing neurosurgical proce-
dures included ischemic or hemorrhagic cerebrovascular 
accident (22; 36.7%), benign or malignant brain tumors 
(20; 33.3%), traumatic brain injury (9; 15.0%) and others 
(9; 15.0%). The mean duration from the first neurosurgi-
cal procedure to the diagnosis of meningitis was 21 days 
(range, 1–134 days). The median frequency of neurosurgi-
cal procedure before meningitis for all 60 patients was 1 
(range, 1–5). Of the 60 patients, 30 (50.0%) had at least one 
comorbid illness. Diabetes mellitus was the most frequent 
(14, 23.3%), followed by malignancy (9, 15.0%) and renal 
insufficiency (7, 11.7%). Fever was the most common clin-
ical manifestation (44, 73.3%), followed by respiratory 
failure (16, 26.7%) and altered consciousness (12, 20.0%). 
Fever and progressive deteriorating consciousness were 
two major clinical presentations, and about 18–26% of 
patients would progress to shock and respiratory failure. 
The initial mean Glasgow Coma Scale (GCS) score on 
presentation was 10 (range, 3–15).
The ranges of CSF routine and biochemistry data were as 
follows: glucose level = 0–206 mg/dL (56.7 ± 38.6 mg/dL); 
total protein = 10.9–5,200 mg/dL (371.4 ± 844.9 mg/dL); 
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lactate = 12.9–359 mg/dL (76.2 ± 80.1 mg/dL); and white 
blood cell count = < 5 to 149,375 cells/uL (5,683.6 ± 
21,182.3 μL). Blood cultures were performed in 30 patients, 
and eight were positive. The organisms grown from blood 
cultures were the same as those from the CSF specimens.
Among these 60 patients, 51 (85.0%) survived and nine 
(15.0%) died. Fifty-three (88.3%) had a monomicrobial infec-
tion and seven (11.7%) had a mixed infection. The causative 
pathogens isolated from the CSF are listed in Table 2. 
Of the total 69 identified isolates, 43 (62.3%) were Gram-
negative organisms, 24 (34.8%) were Gram-positive organ-
isms, and two (2.9%) were anaerobes. The leading GNB were 
Enterobacteriaceae (28, 40.6%) and glucose non-fermenting 
GNB (15, 21.7%). The Gram-positive bacteria were as fol-
lows: Staphylococcus aureus (10, 14.5%), coagulase-negative 
staphylococci (CoNS, including S. epidermidis) (10, 14.5%), 
Table 2. The 69 cerebrospinal fluid isolates from 60 patients 
with post-neurosurgical meningitis
Organisma n (%)
Gram-negative organisms 43 (62.3)
Enterobacteriaceae 28 (40.6)
Serratia marcescens 7 (10.1)
Klebsiella pneumoniae 6 (8.7)
Enterobacter cloacae 4 (5.8)
Klebsiella oxytoca 3 (4.3)
Escherichia coli 3 (4.3)
Morganella morganii 1 (1.4)
Proteus vulgaris 1 (1.4)
Enterobacter aerogenes 1 (1.4)
Escherichia hermannii 1 (1.4)
Citrobacter freundii 1 (2.3)
Glucose non-fermenting GNB 15 (21.7)
Acinetobacter spp.b 3 (4.3)
Acinetobacter baumannii 2 (2.9)
Pseudomonas aeruginosa 2 (2.9)
Sphingomonas paucimobilis 2 (2.9)
Stenotrophomonas maltophilia 1 (1.4)
Others 5 (7.2)
Gram-positive organisms 24 (34.8)
Staphylococcus aureusc 10 (14.5)
Coagulase-negative staphylococcid 10 (14.5)
Enterococcus faecalis 1 (1.4)
Enterococcus durans 1 (1.4)
β-Streptococcus Gr. D 1 (1.4)
Bacillus spp. 1 (1.4)
Anaerobes 2 (2.9)
Propionibacterium acnes 2 (2.9)
aPolymicrobial isolates were present in patient or one specimen; 
bAcinetobacter baumannii was not included; ctwo isolates were methicillin-
sensitive and eight isolates were methicillin-resistant; dStaphylococcus 
epidermidis (n = 3), Staphylococcus capitis (n = 1), and other unidentified 
coagulase-negative Staphylococci (n = 6). GNB = Gram-negative bacilli.
Table 1. Demographic and clinical characteristics of 60 
patients with post-neurosurgical bacterial meningitis
Characteristics Valuea
Demographic parameters
 Mean age (yr) 56 ± 15
 Sex, male:female 30:30
 Episodes of neurosurgery before 1.0 (1–5)
  meningitis
 Interval between meningitis and 21.0 ± 24.9
  the initial neurosurgery (d)
Symptoms on presentation
 Fever 44 (73.3)
 Headache 11 (18.3)
 Neck stiffness 3 (5.0)
 Seizure 5 (8.3)
 Altered consciousness 12 (20.0)
 Nausea or vomiting 7 (11.7)
 Shock 11 (18.3)
 Respiratory failure 16 (26.7)
Initial Glasgow Come Scales score 10 ± 4
on presentation
CSF datab
 Leukocyte count (/uL) 5,683.6 ± 21,182.3
 Neutrophil (%) 57.9 ± 39.4
 Glucose level (mg/dL)c 56.7 ± 38.6
 Protein level (mg/dL) 371.4 ± 844.9
 Lactate level (mg/dL) 76.2 ± 80.1
 Positive Gram stain result 47 (70.0)
Peripheral blood studyb
 Serum leukocyte count (/uL) 13,370.1 ± 5,415.5
 Platelet count (/uL) 288,121.4 ± 130,950.9
 CRP (mg/L) 102.2 ± 106.3
 Bacteremia 8 (26.7)
Mortality 9 (15.0)
aData presented as n (%), mean ± standard deviation or median 
(range); bnot every patient had every tests; cCSF sugar < 5 mg/dL was 
counted as 0. CSF = cerebrospinal fluid; CRP = C-reactive protein.
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Enterococcus spp. (2, 2.9%), Streptococcus spp. (1, 1.4%), and 
Bacillus spp. (1, 1.4%).
The three most common GNB were Serratia marcescens 
(7, 10.1%), Klebsiella pneumoniae (6, 8.7%), and Enterobacter 
cloacae (4, 5.8%). Pseudomonas aeruginosa and Acinetobacter 
baumannii isolates comprised less than 3%. Notably, glu-
cose non-fermenting GNB other than Acinetobacter and 
Pseudomonas spp. accounted for 11.6% of the total isolates. 
S. aureus and CoNS (including S. epidermidis) were the two 
most common Gram-positive pathogens. The antimicro-
bial resistance of the causative organisms is listed in Table 3. 
Among the 43 GNB isolates on the initial positive CSF 
sampling, 25 (58.1%) were resistant to ceftriaxone, 15 (34.9%) 
were resistant to ceftazidime, and five (11.6%) were resis-
tant to carbapenems. All four E. cloacae isolates were re-
sistant to ceftriaxone and ceftazidime, and 5/15 glucose 
non-fermenting GNB isolates were resistant to ceftazi-
dime. In comparison with the GNB isolates susceptible to 
third-generation cephalosporins, those isolates resistant 
to third-generation cephalosporins had the higher rate 
of third-generation cephalosporin exposure ≥ 72 hours 
within 2 weeks before the onset of meningitis, but there 
was no statistically significant difference between these 
two groups (32.0% vs. 11.1%; p = 0.153). Of the 10 S. aureus 
isolates, eight (80%) were methicillin-resistant strains, and 
five (50%) implicated CoNS isolates were also methicillin-
resistant. As disk testing is not reliable for vancomycin, 
the susceptibilities of the CoNS and S. aureus isolates to 
vancomycin remain unknown.
The analysis of potential risk factors for in-hospital 
mortality is listed in Table 4. Univariate analysis compari-
son between the surviving and deceased patients revealed 
the following significant factors: shock (p = 0.05), res-
piratory failure (p = 0.001), low GCS score at the onset 
of meningitis (p = 0.002), and decreased platelet count 
(p = 0.019). Variables used in multivariate analysis (Table 5) 
included shock, respiratory failure, initial GCS score, 
platelet count and GNB in CSF culture for module A. For 
modules B and C, we replaced the variable, “GNB”, with 
“third-generation cephalosporin sensitive” and “third-
generation cephalosporin resistant” GNB, respectively. 
After analysis of the aforementioned variables, the pres-
ence of third-generation cephalosporin resistant GNB 
in the CSF (p = 0.047) was independently associated with 
in-hospital mortality for patients with post-neurosurgical 
meningitis.
Discussion
In this study, several findings are of interest. First, an ob-
vious increase in GNB isolated from the CSF specimens of 
the patients with post-neurosurgical meningitis was noted. 
GNB were responsible for 62.3% of the total isolates. The 
ratio of GNB to Gram-positive pathogens was about 1.7:1, 
Table 3. Antimicrobial resistance of the causative organisms from the cerebrospinal fluid of 60 patients with post-neurosurgical 
meningitisa
 Gram-negative organisms
Antimicrobial Serratia Klebsiella Enterobacter Glucose 
Total
 Gram-positive
agentb marcescens pneumoniae cloacae non-fermenting GNBc 
(n = 43)
 organisms
 (n = 7) (n = 6) (n = 4) (n = 15)
Ceftriaxoned 0 (0) 1 (16.7) 4 (100) 15 (100) 25 (58.1) –
Ceftazidime 0 (0) 1 (16.7) 4 (100) 5 (33.3) 15 (34.9) –
Cefepime 0 (0) 1 (16.7) 4 (100) 3 (20.0) 12 (27.9) –
Carbapenems 0 (0) 0 (0) 0 (0) 5 (33.3) 5 (11.6) –
Oxacillin – – – – – 13 (65.0)e
Vancomycin – – – – – 0 (0.0)f
aData presented as n (%); bStenotrophomonas maltophilia was viewed as intrinsic resistance to ceftazidime, ceftriaxone, cefepime and carbapen-
ems;27,28 cincluding Acinetobacter spp. (n = 5), Pseudomonas spp. (n = 2), Sphingomonas paucimobilis (n = 2), Stenotrophomonas maltophilia (n = 1), other 
unidentified glucose non-fermenting GNB (n = 5); dglucose non-fermenting GNB were resistant to ceftriaxone; esusceptibility testing was available 
for 20 isolates; fsusceptibility testing was available for 23 isolates. GNB = Gram-negative bacilli.
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Table 4. Univariate analysis of risk factors for in-hospital mortality in patients with post-neurosurgical meningitis
Variables Survivala (n = 51) Deceaseda (n = 9) OR (95% CI) p
Demographic parameters
 Age (yr) 56 ± 15 58 ± 15 – 0.688
 Sex, female 23 (45.1) 7 (77.8) 4.26 (0.09–0.81) 0.145
Conditions for neurosurgery
 CVA 19 (37.3) 3 (33.3) 0.84 (0.19–3.77) 1.000
 Brain tumor 18 (35.3) 2 (22.2) 0.52 (0.10–2.79) 0.704
 Traumatic brain injury  7 (13.7) 2 (22.2) 1.80 (0.31–10.46) 0.612
 Othersb  7 (13.7) 2 (22.2) 1.80 (0.31–10.46) 0.612
Interval between meningitis and 20 ± 21 25 ± 41 – 0.557
 the initial neurosurgery (d)
Comorbid illnessc
 Hepatic dysfunction 2 (3.9) 1 (11.1) 3.06 (0.25–37.84) 0.391
 Renal insufficiency 5 (9.8) 2 (22.2) 2.63 (0.43–16.27) 0.281
 Diabetes mellitus 11 (21.6) 3 (33.3) 1.82 (0.39–8.47) 0.423
 Malignancy  6 (11.8) 3 (33.3) 3.75 (0.74–19.08) 0.125
Symptoms on presentationc
 Shock  7 (13.7) 4 (44.4) 5.03 (1.08–23.40) 0.050
 Respiratory failure  9 (17.6) 7 (77.8) 16.33 (2.90–91.99) 0.001
Initial GCS score on presentation 11.0 ± 3.4 7.1 ± 3.2 – 0.002
CSF datac
 Glucose level (mg/dL) 59.8 ± 37.8 37.1 ± 40.3  0.150
Peripheral blood studyc
 Platelet count (/uL) 305,872 ± 122,117 195,422 ± 143,623  0.019
 CRP (mg/L) 83.0 ± 78.0 191.0 ± 169.7  0.118
Neurosurgery-related
 Re-operation times after meningitis 1.3 ± 1.9 1.2 ± 1.0 – 0.890
 Implanted CSF deviced 41 (80.4) 7 (77.8) 0.85 (0.15–4.75) 1.000
 Post-operation CSF leakage 10 (19.6) 2 (22.2) 1.17 (0.21–6.52) 1.000
Recurrence or relapse
 Recurrence  7 (13.7) 0 (0.0) 0.31 (0.02–5.95) 0.580
 Relapse 3 (5.9) 0 (0.0) 0.73 (0.03–15.30) 1.000
Microbiology
 CSF culture ≥ 2 isolates 5 (9.8) 2 (22.2) 2.63 (0.43–16.26) 0.281
 Gram-negative pathogen 29 (56.9) 7 (77.8) 2.65 (0.50–14.05) 0.293
 Third-generation cephalosporin 16 (31.4)  5 (55.6) 2.73 (0.65–11.56) 0.255
  resistant GNB
Appropriate antimicrobial therapy
 “Initial” therapye 22 (43.1) 6 (66.7) 2.64 (0.59–11.73) 0.281
 Duration of therapy (d) 24 ± 29 24 ± 23 – 0.967
aCategorical data presented as n (%) of patient while continuous data presented as mean ± standard deviation; baneurysm (n = 1), cerebrospinal 
fluid rhinorrhea (n = 2), hydrocephalus (n = 4), skull deformity (n = 2); conly variables of p < 0.05 and selected non-significant on univariate 
analysis are shown; dexternal ventricular drain or ventriculorperitoneal shunt (external lumbar cistern drain was not included); egiven within 
24 hours of presentation of meningitis. OR = Odds ratio; CI = confidential interval; CSF = cerebrospinal fluid; CRP = C-reactive protein; 
CVA = cerebrovascular accident; GNB = Gram-negative bacilli; GCS = Glasgow Come Scale.
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which appeared much higher than that observed in previ-
ous studies (around 0.12:1 to 1.04:1).1,3,14,15 One possible 
explanation for this higher ratio is the frequent aspiration 
of gastric contents with colonization of Gram-negative 
aerobes in head-injured patients,16 or the broadly empirical 
use of vancomycin for post-surgical infections.7
Second, the finding of microbiologic distribution is not 
in accordance with the results of previous studies.11,13,17,18 
This study revealed the emergence of the uncommon CNS 
pathogens, S. marcescens and glucose non-fermenting GNB 
other than Acinetobacter spp. and P. aeruginosa. S. marcescens 
and K. pneumoniae were the two most common GNB in 
the post-neurosurgical meningitis, which accounted for 
10.1% and 8.7%, respectively. In most of the published stud-
ies regarding Gram-negative bacillary meningitis, the com-
mon causative micro-organisms in post-neurosurgical 
meningitis were Escherichia coli, K. pneumoniae, and P. aeru-
ginosa.17,19 In Taiwan, K. pneumoniae has been a very common 
pathogen of acute bacterial meningitis and most cases 
were spontaneous and community-acquired infections.20 
Klebsiella meningitis has been frequently reported in patients 
with alcoholic liver disease and diabetes mellitus.21,22 
Although the incidence of Klebsiella meningitis decreased 
in this study, K. pneumoniae remained the commonly 
implicated pathogen.
S. marcescens, rather than P. aeruginosa, was the most 
common pathogen isolated from the CSF cultures in this 
study. S. marcescens, a rare pathogen in adult CNS infec-
tions, is recognized as a member of the Enterobacteriaceae 
and has been recovered from various sources.23 It has been 
implicated in outbreaks of nosocomial infections in both 
neonates and adults.24 Adult patients who have experi-
enced head trauma or have undergone neurosurgery are at 
risk of developing S. marcescens CNS infection.25 Compared 
with many other studies, we report an apparently larger 
number of S. marcescens meningitis episodes during a rela-
tively short period of 2 years.
Third, the increasing number of third-generation 
cephalosporin-resistant GNB isolates challenges the 
existing therapeutic options for this serious CNS infec-
tion after neurosurgery. Third-generation cephalosporins 
have been widely used for the treatment of patients with 
Table 5. Multivariate analysis of risk factors for in-hospital mortality in nine deceased cases
 Module A Module B Module C
Variablesa Adjusted OR
 p 
Adjusted OR
 p 
Adjusted OR 
p
 (95% CI)  (95% CI)  (95% CI)
GNB in CSF 1.39 (0.18–10.60) 0.753 – – – –
Third-generation – – 0.02 (0.00–1.03) 0.052 – –
cephalosporin sensitive
GNB in CSFb
Third-generation – – – – 33.65 (1.05–1,083.35) 0.047
cephalosporin resistant
GNB in CSF
Shock 0.67 (0.06–7.88) 0.747 0.81 (0.05–12.69) 0.878 1.66 (0.08–35.95) 0.748
Respiratory failure 6.86 (0.84–56.01) 0.072 19.36 (1.30–289.12) 0.032 30.33 (0.95–968.00) 0.053
Initial GCS score 1.00 (1.00–1.00) 0.172 1.37 (0.94–2.01) 0.104 1.19 (0.85–1.66) 0.307
on presentation
Platelet count 1.24 (0.91–1.69) 0.129 1.00 (1.00–1.00) 0.027 1.00 (1.00–1.00) 0.083
aAll variables included in the final multivariable model are shown; bthird-generation cephalosporin sensitive GNB refer to GNB susceptible to 
ceftriaxone and ceftazidime. OR = Odds ratio; CI = confidential interval; CSF = cerebrospinal fluid; GCS = Glasgow Come Scale; GNB = Gram-
negative bacilli.
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post-neurosurgical meningitis because these antibiotics 
penetrate well into the CSF after intravenous administration 
and this has resulted in dramatic decrease in meningitis-
related mortality.26 This study shows the spread of serious 
resistance to third-generation cephalosporins in nosoco-
mial GNB throughout neurosurgical units. Before the start 
of treatment, GNB resistance to ceftriaxone and ceftazi-
dime was 58.1% and 34.9%, respectively. Likewise, antimi-
crobial resistance has been reported in other studies,16,17 
but we report a quite large number of resistant strains in 
Taiwan. The reason for this high resistant rate to third-
generation cephalosporins is probably attributable to the 
emergence of third-generation cephalosporin-resistant 
pathogens, e.g. K. pneumoniae, E. cloacae and glucose non-
fermenting GNB. Univariate analysis showed that there 
was no statistically significant relationship between third-
generation cephalosporin exposure (at least 72 hours) 
within 2 weeks before the onset of meningitis and third-
generation cephalosporin resistance of GNB (p = 0.153). 
Further research is needed to determine why these resistant 
strains are increasing.
Post-neurosurgical meningitis is still a high mortality 
disease (15.0%, 9/60 in this study). Many potential prog-
nostic factors were analyzed, but only the presence of 
shock, respiratory failure, low GCS score at the onset of 
meningitis, and decreased platelet count were associated 
with the prognosis by univariate analysis. Although the pres-
ence of GNB in the CSF was not significantly related to 
death, the data reflect a strong trend towards in-hospital 
mortality (77.8 % vs. 56.9%; p = 0.293). Subsequently, mul-
tivariate analysis showed that only the presence of third-
generation cephalosporin resistant GNB in the CSF was 
independently associated with in-hospital mortality (p = 
0.047; Table 5, module C). This finding challenges the 
current concept regarding the choice of empiric antibiotic 
regimen for post-neurosurgical meningitis. Carbapenems 
have been recommended as the initial choice of empiric 
therapy for post-neurosurgical meningitis probably caused 
by Gram-negative bacteria.10,17 Although we have investi-
gated the impact of third-generation cephalosporin re-
sistant GNB on in-hospital mortality, further research 
and constant epidemiologic trend analysis still needed to 
clarify this observation. Although this study is limited by 
low case numbers and a short study period, it is hoped 
that it can serve as the basis for further study.
In conclusion, Gram-negative pathogens, especially 
third-generation cephalosporin-resistant strains, have be-
come increasingly common as the causative pathogens of 
CNS infection in post-neurosurgical patients. Prudent 
use of antibiotics requires that clinical decision-making 
takes into account both the risk to the individual patient 
if not covered appropriately for a certain pathogen, and 
the risks associated with overuse of antibiotics. Based on 
this study, empiric use of third-generation cephalosporins 
should be reassessed in patients with post-neurosurgical 
meningitis and it would be sensible to initiate further 
studies of other potentially effective agents such as car-
bapenem as the early empiric therapy. Although this pre-
liminary study cannot conclude that the empiric use of 
carbapenem improves the survival of patients with post-
neurosurgical meningitis, we suggest further investiga-
tions be carried out into this possibility.
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